Denali Therapeutics Inc.
DNLIFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Denali Therapeutics Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 2026-03-31 | 78,007 | $1.5M | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 768,039 | $14.7M | SEC filing |
| Cullen/Frost Bankers, Inc. | 2026-03-31 | 10 | $192 | SEC filing |
| Amundi | 2026-03-31 | 18,604 | $357K | SEC filing |
| Atlantic Private Wealth, LLC | 2026-03-31 | 10 | $192 | SEC filing |
| TD Asset Management Inc | 2026-03-31 | 255,766 | $4.91M | SEC filing |
| XPONANCE LLC | 2026-03-31 | 13,240 | $254K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 323,989 | $5.86M | SEC filing |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 2026-03-31 | 34,168 | $656K | SEC filing |
| ARIZONA STATE RETIREMENT SYSTEM | 2026-03-31 | 38,153 | $733K | SEC filing |
| NBC SECURITIES, INC. | 2026-03-31 | 7,617 | $146K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 189 | $3.63K | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 107,657 | $2.07M | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 3,727,114 | $71.6M | SEC filing |
| DAFNA Capital Management LLC | 2026-03-31 | 318,500 | $6.12M | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 1,428 | $27.4K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 46,642 | Not shown | SEC filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2026-03-31 | 296,503 | $5.69M | SEC filing |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2026-03-31 | 114,524 | $2.2M | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 62 | $1.19K | SEC filing |
- Each value is checked against Denali Therapeutics Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Denali Therapeutics Inc.'s share price.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-06 | Watts Ryan J. · President and CEO | Common Stock | S — Open market or private sale | −35,198 | 16.50 | SEC filing |
| 2026-01-06 | Schuth Alexander O. · COFO and Secretary | Common Stock | S — Open market or private sale | −17,218 | 16.50 | SEC filing |
| 2025-12-11 | BAKER JULIAN · Director | $0.01 Prefunded Warrants | P — Open market or private purchase | +2,095,191 | 17.49 | SEC filing |
| 2025-12-11 | BAKER JULIAN · Director | $0.01 Prefunded Warrants | P — Open market or private purchase | +190,523 | 17.49 | SEC filing |
| 2025-08-13 | Ho Carole · Chief Medical Officer | Common Stock | S — Open market or private sale | −806 | 14.64 | SEC filing |
| 2025-08-12 | Ho Carole · Chief Medical Officer | Common Stock | S — Open market or private sale | −2,937 | 13.58 | SEC filing |
| 2025-08-12 | Schuth Alexander O. · COFO and Secretary | Common Stock | S — Open market or private sale | −2,937 | 13.58 | SEC filing |
| 2025-07-09 | Watts Ryan J. · President and CEO | Common Stock | S — Open market or private sale | −495,282 | 15.00 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | FLATLEY JAY T · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +19,226 | SEC filing |
| 2026-06-03 | BAKER JULIAN · Director | Common Stock | A — Grant, award, or other acquisition | +6,408 | SEC filing |
| 2026-06-03 | Krognes Steve E. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +19,226 | SEC filing |
| 2026-06-03 | Klein Peter S · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +19,226 | SEC filing |
| 2026-06-03 | FLATLEY JAY T · Director | Common Stock | A — Grant, award, or other acquisition | +6,408 | SEC filing |
| 2026-06-03 | BAKER JULIAN · Director | Non- Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +19,226 | SEC filing |
| 2026-06-03 | Thornberry Nancy · Director | Common Stock | A — Grant, award, or other acquisition | +6,408 | SEC filing |
| 2026-06-03 | Schenkein David P · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +19,226 | SEC filing |
Showing 8 of 22 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.